Second-line agents in the treatment of rheumatic diseases:
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
New York u.a.
Dekker
1992
|
| Schriftenreihe: | Inflammatory disease and therapy
9 |
| Schlagworte: | |
| Beschreibung: | XV, 621 S. Ill. |
| ISBN: | 082478541X |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV004733832 | ||
| 003 | DE-604 | ||
| 007 | t| | ||
| 008 | 920310s1992 xx a||| |||| 00||| engod | ||
| 020 | |a 082478541X |9 0-8247-8541-X | ||
| 035 | |a (OCoLC)24174351 | ||
| 035 | |a (DE-599)BVBBV004733832 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-12 |a DE-355 |a DE-29 | ||
| 050 | 0 | |a RC927 | |
| 082 | 0 | |a 616.7/23061 |2 20 | |
| 084 | |a XI 5100 |0 (DE-625)153011:12905 |2 rvk | ||
| 245 | 1 | 0 | |a Second-line agents in the treatment of rheumatic diseases |c ed. by Jonathan S. Dixon ... |
| 264 | 1 | |a New York u.a. |b Dekker |c 1992 | |
| 300 | |a XV, 621 S. |b Ill. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Inflammatory disease and therapy |v 9 | |
| 650 | 4 | |a Antirhumatismaux - Essais | |
| 650 | 4 | |a Polyarthrite rhumatoïde - Chimiothérapie | |
| 650 | 4 | |a Rhumatisme - Chimiothérapie | |
| 650 | 2 | |a Rhumatismes - Traitement médicamenteux | |
| 650 | 2 | |a Rhumatismes | |
| 650 | 4 | |a Antirheumatic agents |x Testing | |
| 650 | 4 | |a Rheumatic Diseases |x drug therapy | |
| 650 | 4 | |a Rheumatism |x Chemotherapy | |
| 650 | 4 | |a Rheumatoid arthritis |x Chemotherapy | |
| 650 | 0 | 7 | |a Pharmakotherapie |0 (DE-588)4076066-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Antirheumatikum |0 (DE-588)4002332-1 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Rheumatismus |0 (DE-588)4049836-0 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Rheumatismus |0 (DE-588)4049836-0 |D s |
| 689 | 0 | 1 | |a Pharmakotherapie |0 (DE-588)4076066-2 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Antirheumatikum |0 (DE-588)4002332-1 |D s |
| 689 | 1 | |5 DE-604 | |
| 700 | 1 | |a Dixon, Jonathan S. |e Sonstige |4 oth | |
| 830 | 0 | |a Inflammatory disease and therapy |v 9 |w (DE-604)BV002648775 |9 9 | |
| 943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-002912128 | |
Datensatz im Suchindex
| _version_ | 1827473036151881728 |
|---|---|
| adam_text | |
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV004733832 |
| callnumber-first | R - Medicine |
| callnumber-label | RC927 |
| callnumber-raw | RC927 |
| callnumber-search | RC927 |
| callnumber-sort | RC 3927 |
| callnumber-subject | RC - Internal Medicine |
| classification_rvk | XI 5100 |
| ctrlnum | (OCoLC)24174351 (DE-599)BVBBV004733832 |
| dewey-full | 616.7/23061 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.7/23061 |
| dewey-search | 616.7/23061 |
| dewey-sort | 3616.7 523061 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nam a2200000 cb4500</leader><controlfield tag="001">BV004733832</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="007">t|</controlfield><controlfield tag="008">920310s1992 xx a||| |||| 00||| engod</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">082478541X</subfield><subfield code="9">0-8247-8541-X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)24174351</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV004733832</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-355</subfield><subfield code="a">DE-29</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC927</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.7/23061</subfield><subfield code="2">20</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XI 5100</subfield><subfield code="0">(DE-625)153011:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Second-line agents in the treatment of rheumatic diseases</subfield><subfield code="c">ed. by Jonathan S. Dixon ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York u.a.</subfield><subfield code="b">Dekker</subfield><subfield code="c">1992</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XV, 621 S.</subfield><subfield code="b">Ill.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Inflammatory disease and therapy</subfield><subfield code="v">9</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antirhumatismaux - Essais</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Polyarthrite rhumatoïde - Chimiothérapie</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Rhumatisme - Chimiothérapie</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Rhumatismes - Traitement médicamenteux</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Rhumatismes</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antirheumatic agents</subfield><subfield code="x">Testing</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Rheumatic Diseases</subfield><subfield code="x">drug therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Rheumatism</subfield><subfield code="x">Chemotherapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Rheumatoid arthritis</subfield><subfield code="x">Chemotherapy</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmakotherapie</subfield><subfield code="0">(DE-588)4076066-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Antirheumatikum</subfield><subfield code="0">(DE-588)4002332-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Rheumatismus</subfield><subfield code="0">(DE-588)4049836-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Rheumatismus</subfield><subfield code="0">(DE-588)4049836-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Pharmakotherapie</subfield><subfield code="0">(DE-588)4076066-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Antirheumatikum</subfield><subfield code="0">(DE-588)4002332-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Dixon, Jonathan S.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Inflammatory disease and therapy</subfield><subfield code="v">9</subfield><subfield code="w">(DE-604)BV002648775</subfield><subfield code="9">9</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-002912128</subfield></datafield></record></collection> |
| id | DE-604.BV004733832 |
| illustrated | Illustrated |
| indexdate | 2025-03-24T11:01:38Z |
| institution | BVB |
| isbn | 082478541X |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-002912128 |
| oclc_num | 24174351 |
| open_access_boolean | |
| owner | DE-12 DE-355 DE-BY-UBR DE-29 |
| owner_facet | DE-12 DE-355 DE-BY-UBR DE-29 |
| physical | XV, 621 S. Ill. |
| publishDate | 1992 |
| publishDateSearch | 1992 |
| publishDateSort | 1992 |
| publisher | Dekker |
| record_format | marc |
| series | Inflammatory disease and therapy |
| series2 | Inflammatory disease and therapy |
| spelling | Second-line agents in the treatment of rheumatic diseases ed. by Jonathan S. Dixon ... New York u.a. Dekker 1992 XV, 621 S. Ill. txt rdacontent n rdamedia nc rdacarrier Inflammatory disease and therapy 9 Antirhumatismaux - Essais Polyarthrite rhumatoïde - Chimiothérapie Rhumatisme - Chimiothérapie Rhumatismes - Traitement médicamenteux Rhumatismes Antirheumatic agents Testing Rheumatic Diseases drug therapy Rheumatism Chemotherapy Rheumatoid arthritis Chemotherapy Pharmakotherapie (DE-588)4076066-2 gnd rswk-swf Antirheumatikum (DE-588)4002332-1 gnd rswk-swf Rheumatismus (DE-588)4049836-0 gnd rswk-swf Rheumatismus (DE-588)4049836-0 s Pharmakotherapie (DE-588)4076066-2 s DE-604 Antirheumatikum (DE-588)4002332-1 s Dixon, Jonathan S. Sonstige oth Inflammatory disease and therapy 9 (DE-604)BV002648775 9 |
| spellingShingle | Second-line agents in the treatment of rheumatic diseases Inflammatory disease and therapy Antirhumatismaux - Essais Polyarthrite rhumatoïde - Chimiothérapie Rhumatisme - Chimiothérapie Rhumatismes - Traitement médicamenteux Rhumatismes Antirheumatic agents Testing Rheumatic Diseases drug therapy Rheumatism Chemotherapy Rheumatoid arthritis Chemotherapy Pharmakotherapie (DE-588)4076066-2 gnd Antirheumatikum (DE-588)4002332-1 gnd Rheumatismus (DE-588)4049836-0 gnd |
| subject_GND | (DE-588)4076066-2 (DE-588)4002332-1 (DE-588)4049836-0 |
| title | Second-line agents in the treatment of rheumatic diseases |
| title_auth | Second-line agents in the treatment of rheumatic diseases |
| title_exact_search | Second-line agents in the treatment of rheumatic diseases |
| title_full | Second-line agents in the treatment of rheumatic diseases ed. by Jonathan S. Dixon ... |
| title_fullStr | Second-line agents in the treatment of rheumatic diseases ed. by Jonathan S. Dixon ... |
| title_full_unstemmed | Second-line agents in the treatment of rheumatic diseases ed. by Jonathan S. Dixon ... |
| title_short | Second-line agents in the treatment of rheumatic diseases |
| title_sort | second line agents in the treatment of rheumatic diseases |
| topic | Antirhumatismaux - Essais Polyarthrite rhumatoïde - Chimiothérapie Rhumatisme - Chimiothérapie Rhumatismes - Traitement médicamenteux Rhumatismes Antirheumatic agents Testing Rheumatic Diseases drug therapy Rheumatism Chemotherapy Rheumatoid arthritis Chemotherapy Pharmakotherapie (DE-588)4076066-2 gnd Antirheumatikum (DE-588)4002332-1 gnd Rheumatismus (DE-588)4049836-0 gnd |
| topic_facet | Antirhumatismaux - Essais Polyarthrite rhumatoïde - Chimiothérapie Rhumatisme - Chimiothérapie Rhumatismes - Traitement médicamenteux Rhumatismes Antirheumatic agents Testing Rheumatic Diseases drug therapy Rheumatism Chemotherapy Rheumatoid arthritis Chemotherapy Pharmakotherapie Antirheumatikum Rheumatismus |
| volume_link | (DE-604)BV002648775 |
| work_keys_str_mv | AT dixonjonathans secondlineagentsinthetreatmentofrheumaticdiseases |